Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Artiva Biotherapeutics, Inc. Common Stock Income Statement Banner

Artiva Biotherapeutics, Inc. Common Stock Income Statement

ARTV Stock Analysis

Page title

Section title

Breakdown
2020
2021
2022
2023
Total Revenue
0.0002.002M4.931M33.492M
Cost of Revenue
0.0000.0000.0000.000
Gross Profit
0.0002.002M4.931M33.492M
Operating Expense
18.271M55.274M64.760M64.163M
Operating Income
-18.271m-53.272m-59.829m-30.671m
Other Income Expense
477.000K-18.553m200.000K-195.000k
Total Other Income Expense
477.000K-18.553m200.000K512.000K
Pretax Income
-17.991m-71.825m-58.335m-27.624m
Tax Provision
676.000K-18.553m53.000K72.000K
Net Income
-17.991m-71.825m-58.388m-27.696m
Basic EPS
-1.020-4.080-3.320-1.580
Diluted EPS
-1.020-4.080-3.320-1.580
Basic Average Shares
17.583M17.583M17.583M17.583M
Diluted Average Shares
17.583M17.583M17.583M17.583M
Total Expenses
18.271M55.274M64.760M64.163M
Interest Income
2.000K0.0001.294M2.535M
Interest Expense
199.000K0.0000.0000.000
EBITDA
-17.719m-71.577m-58.671m-29.112m
Depreciation & Amortization
73.000K248.000K1.158M2.266M